Upside case
Bull case
$18-76.6%
The bull case prices IFF at 4x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Analysis OverviewBuyUpdated Jun 18, 2026
International Flavors & Fragrances Inc. (IFF) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Buy
Covering
33
analysts
24 bullish · 1 bearish · 33 covering IFF
Strong Buy
0
Buy
24
Hold
8
Sell
1
Strong Sell
0
Consensus Target
$88
+14.9% vs today
Scenario Range
$9 – $18
Model bear to bull value window
Coverage
33
Published analyst ratings
Valuation Context
17.3x
Forward P/E · Market cap $19.6B
IFF price targets
Three scenarios for where IFF stock could go
Current
~$77
Confidence
45 / 100
Updated
Jun 18, 2026
Where we are now
Current · $77
Bear
$9
Base
$14
Bull
$18
Market caseClosest to today
Base case
$14-82.3%
At 3x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
Stress case
Bear case
$9-88.8%
If investor confidence fades or macro conditions deteriorate, a 15x multiple contraction could push IFF down roughly 89% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
International Flavors & Fragrances Inc.
IFF · NYSEBasic MaterialsChemicals - SpecialtyDecember year-end
International Flavors & Fragrances is a global creator of taste, scent, and nutrition ingredients for consumer products. It generates revenue primarily through its Nourish segment (flavors and food ingredients), Scent segment (fragrance compounds and ingredients), and Health & Biosciences segment (enzymes and probiotics) — with each contributing roughly one-third of sales. The company's competitive advantage lies in its extensive R&D capabilities, proprietary ingredient libraries, and deep customer relationships across the food, beverage, fragrance, and personal care industries.
Market Cap
$19.6B
Revenue TTM
$10.8B
Net Income TTM
$839M
Net Margin
7.8%
IFF Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
67%Exceptional
12 quarters tracked
Revenue Beat Rate
92%Exceptional
vs consensus estimates
Avg EPS Surprise
+6.6%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Last 4 Quarters
EPS beats: 3 of 4Q3 2025
EPS
$1.15/$1.12
Revenue
$2.8B/$2.7B
Q4 2025
EPS
$1.05/$1.02
Revenue
$2.7B/$2.6B
Q1 2026
EPS
$0.80/$0.83
Revenue
$2.6B/$2.5B
Q2 2026
EPS
$1.25/$1.07
Revenue
$2.7B/$2.6B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.15/$1.12 | +2.7% | $2.8B/$2.7B | +2.3% |
| Q4 2025 | $1.05/$1.02 | +2.9% | $2.7B/$2.6B | +2.3% |
| Q1 2026 | $0.80/$0.83 | -3.4% | $2.6B/$2.5B | +3.0% |
| Q2 2026 | $1.25/$1.07 | +16.8% | $2.7B/$2.6B | +3.7% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$10.9B
+0.8% YoY
FY2
$10.8B
-0.5% YoY
EPS Outlook
FY1
$2.11
-35.5% YoY
FY2
$1.36
-35.4% YoY
Trailing FCF (TTM)$400M
FCF Margin: 3.7%
Next Earnings
August 4, 2026
Expected EPS
$1.14
Expected Revenue
$2.7B
IFF beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
IFF Revenue Breakdown by Segment
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest disclosure
FY 2025
Total disclosed revenue $10.9B
Product Mix
Latest annual revenue by segment or product family
Food Ingredients
30.1%
YoY unavailable
Tap, hover, or focus a slice to inspect segment detail.
Geographic Mix
Latest annual revenue by reported region
EMEA
26.7%
-2.9% YoY
Tap, hover, or focus a slice to inspect segment detail.
Food Ingredients is the largest disclosed segment at 30.1% of FY 2025 revenue, with no year-over-year comparison yet.
EMEA is the largest reported region at 26.7%, down 2.9% YoY.
IFF Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Fair versus peers
Fair value est. $78 — implies +2.1% from today's price.
Upside to Fair Value
2.1%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
IFF
-52.5x
vs
S&P 500
24.4x
315% discount
vs Basic Materials Trailing P/E
IFF
-52.5x
vs
Basic Materials
23.6x
323% discount
vs IFF 5Y Avg P/E
Today
-52.5x
vs
5Y Average
113.0x
147% discount
Forward PE
17.3x
S&P 500
18.8x
-8%
Basic Materials
14.9x
+16%
5Y Avg
—
—
Trailing PE
-52.5x
S&P 500
24.4x
-315%
Basic Materials
23.6x
-323%
5Y Avg
113.0x
-147%
PEG Ratio
—
S&P 500
1.66x
—
Basic Materials
1.23x
—
5Y Avg
—
—
EV/EBITDA
13.1x
S&P 500
15.2x
-14%
Basic Materials
11.0x
+19%
5Y Avg
18.9x
-31%
Price/FCF
76.6x
S&P 500
20.7x
+270%
Basic Materials
29.0x
+164%
5Y Avg
40.2x
+91%
Price/Sales
1.8x
S&P 500
3.1x
-42%
Basic Materials
1.9x
-4%
5Y Avg
2.1x
-15%
Dividend Yield
2.08%
S&P 500
1.91%
+9%
Basic Materials
1.41%
+48%
5Y Avg
2.72%
-23%
| Metric | IFF | S&P 500 | Basic Materials | 5Y Avg IFF |
|---|---|---|---|---|
| Forward PE | 17.3x | 18.8x | 14.9x+16% | — |
| Trailing PE | -52.5x | 24.4x-315% | 23.6x-323% | 113.0x-147% |
| PEG Ratio | — | 1.66x | 1.23x | — |
| EV/EBITDA | 13.1x | 15.2x-14% | 11.0x+19% | 18.9x-31% |
| Price/FCF | 76.6x | 20.7x+270% | 29.0x+164% | 40.2x+91% |
| Price/Sales | 1.8x | 3.1x-42% | 1.9x | 2.1x-15% |
| Dividend Yield | 2.08% | 1.91% | 1.41% | 2.72% |
IFF trades above S&P 500 benchmarks on 1 of 5 measured multiples — appears modestly priced relative to the S&P 500 on most measures.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolIFF Financial Health
Verdict
Stressed
IFF returns 2.3% of market cap to shareholders annually.
Cash Engine
Revenue, margins, and cash generation
Revenue (TTM)
Trailing-twelve-month sales base
$10.8B
Revenue Growth
TTM vs prior year
-5.6%
Gross Margin
Gross profit as a share of revenue
35.1%
Operating Margin
Operating income divided by revenue
8.0%
Net Margin
Net income divided by revenue
7.8%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$3.26
Free Cash Flow (TTM)
Cash generation after capex
$400M
FCF Margin
FCF as share of revenue — the primary cash quality signal
3.7%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
3.5%
ROA
Return on assets, trailing twelve months
3.3%
Cash & Equivalents
Liquid assets on the balance sheet
$590M
Net Debt
Total debt minus cash
$6.1B
Debt Serviceability
Net debt as a multiple of annual free cash flow
15.2× FCF
~15.2 years to full repayment at current FCF run-rate
ROE
Return on equity, trailing twelve months
5.9%
Shareholder Returns
How capital is returned to owners
Total shareholder yield
2.3%
Dividend
2.1%
Buyback
0.2%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$38M
Dividend / Share
Annualized trailing dividend per share
$1.60
Payout Ratio
Share of earnings distributed as dividends
—
Shares Outstanding
Declining as buybacks retire shares
255M
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageIFF Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
High Risk
Integration Challenges
The company faces significant operational and financial challenges post-merger with DuPont's Nutrition & Biosciences, including complex integration and customer inventory issues.
High Risk
Operational Disruptions
Severe customer inventory disruptions have been reported, impacting the company's ability to meet demand and maintain profitability.
Medium
Financial Sensitivity
Sensitivity analysis highlights potential valuation shifts due to changes in revenue growth, margins, and discount rates, indicating financial volatility.
Medium
Market Sentiment
Wall Street debates and mixed analyst ratings (e.g., $88 consensus target) reflect uncertainty about the company's near-term performance.
Lower
Competitive Pressure
The merger with DuPont's N&B business, while transformative, may expose the company to heightened competitive pressures in the flavors and fragrances industry.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why IFF Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Strategic divestiture and investment
IFF is selling its Food Ingredients business for $4.30 billion while retaining a stake and board seat, and investing in sustainable natural ingredients research in Grasse.
Health and wellness trends
IFF is positioned as a behind-the-scenes player benefiting from growing consumer demand for health and wellness products through ingredient innovation.
Sustainable ingredient research
The opening of a new experimental field in Grasse highlights IFF's commitment to advancing research into sustainable natural ingredients.
Attractive valuation metrics
As of June 13, IFF's forward P/E ratio was 18.25, suggesting potential undervaluation relative to growth prospects.
Behind-the-scenes market position
IFF's role as an ingredient supplier provides stable demand and less direct consumer market volatility.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
IFF Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$76.72
52W Range Position
70%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$59.14
+29.7% from the low
52-Week High
$84.19
-8.9% from the high
1 Month
+4.10%
3 Month
+12.31%
YTD
+12.8%
1 Year
+2.4%
3Y CAGR
-1.1%
5Y CAGR
-11.9%
10Y CAGR
-4.9%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
IFF vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
17.3x
vs 19.8x median
-13% below peer median
Revenue Growth
+0.8%
vs +3.8% median
-79% below peer median
Net Margin
7.8%
vs 4.8% median
+62% above peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
IFF IFF International Flavors & Fragrances Inc. | $19.6B | 17.3x | +0.8% | 7.8% | Buy | +14.9% |
SHW SHW The Sherwin-Williams Company | $79.1B | 27.4x | +3.8% | 10.9% | Buy | +16.8% |
FMC FMC FMC Corporation | $1.4B | 6.8x | +2.7% | -72.9% | Hold | +39.4% |
AVN AVNT Avient Corporation | $3.5B | 12.2x | +1.5% | 4.8% | Buy | +24.0% |
BCP BCPC Balchem Corporation | $5.3B | 31.7x | +8.8% | 15.0% | Buy | +5.8% |
SEN SENS Senseonics Holdings, Inc. | $282M | — | +15.9% | -214.2% | Buy | +63.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
IFF Dividend and Capital Return
IFF returns 2.3% total yield, led by a 2.08% dividend.
Dividend UnknownFCF Stretched
Total Shareholder Yield
2.3%
Dividend + buyback return per year
Buyback Yield
0.2%
Dividend Yield
2.08%
Payout Ratio
—
How IFF Splits Its Return
Div 2.08%
Dividend 2.08%Buybacks 0.2%
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$1.60
Growth Streak
Consecutive years of dividend increases
0Y
3Y Div CAGR
-20.6%
5Y Div CAGR
-12.0%
Ex-Dividend Date
—
Payment Cadence
Semi-Annual
5 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$38M
Estimated Shares Retired
495.3K
Approx. Share Reduction
0.2%
Shares Outstanding
Current diluted share count from the screening snapshot
255M
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.80 | — | — | — |
| 2025 | $1.60 | 0.0% | 0.2% | 2.6% |
| 2024 | $1.60 | -50.6% | 0.1% | 2.4% |
| 2023 | $3.24 | +1.3% | 0.0% | 4.0% |
| 2022 | $3.20 | +2.6% | 0.0% | 3.0% |
FAQ
7 questionsIFF Investor Questions
Common questions answered from live analyst data and company financials.
01Is International Flavors & Fragrances Inc. (IFF) stock a buy or sell in 2026?
International Flavors & Fragrances Inc. (IFF) is rated Buy by Wall Street analysts as of 2026. Of 33 analysts covering the stock, 24 rate it Buy or Strong Buy, 8 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $88, implying +14.9% from the current price of $77. The bear case scenario is $9 and the bull case is $18.
02What is the IFF stock price target for 2026?
The Wall Street consensus price target for IFF is $88 based on 33 analyst estimates. The high-end target is $95 (+23.8% from today), and the low-end target is $75 (-2.2%). The base case model target is $14.
03Is International Flavors & Fragrances Inc. (IFF) stock overvalued in 2026?
IFF trades at 17.3x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals fair versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for International Flavors & Fragrances Inc. (IFF) stock in 2026?
The primary risks for IFF in 2026 are: (1) Integration Challenges — The company faces significant operational and financial challenges post-merger with DuPont's Nutrition & Biosciences, including complex integration and customer inventory issues. (2) Operational Disruptions — Severe customer inventory disruptions have been reported, impacting the company's ability to meet demand and maintain profitability. (3) Financial Sensitivity — Sensitivity analysis highlights potential valuation shifts due to changes in revenue growth, margins, and discount rates, indicating financial volatility. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is International Flavors & Fragrances Inc.'s revenue and earnings forecast?
Analyst consensus estimates IFF will report consensus revenue of $10.9B (+0.8% year-over-year) and EPS of $2.11 (-35.5% year-over-year) for the upcoming fiscal year. The following year, analysts project $10.8B in revenue.
06When does International Flavors & Fragrances Inc. (IFF) report its next earnings?
International Flavors & Fragrances Inc. is expected to report its next earnings on approximately 2026-08-04. Consensus expects EPS of $1.14 and revenue of $2.7B. Over recent quarters, IFF has beaten EPS estimates 67% of the time.
07How much free cash flow does International Flavors & Fragrances Inc. generate?
International Flavors & Fragrances Inc. (IFF) generated $400M in free cash flow over the trailing twelve months — a free cash flow margin of 3.7%. IFF returns capital to shareholders through dividends (2.1% yield) and share repurchases ($38M TTM).